A Novel Interplay between Rap1 and PKA Regulates Induction of Angiogenesis in Prostate Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Menon, Jyotsana ^a   Doebele, Robert C ^b   Gomes, Suzana ^a   Bevilacqua, Elena ^a   Reindl, Katie M ^c   Rosner, Marsha Rich ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; RAP1 PROTEIN; RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; RAP1 GTP-BINDING PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84869204666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049893     Document Type: Article

References (43)

1. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
2. Carmeliet P, (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
3. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
4. Carmeliet P, Tessier-Lavigne M, (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436: 193-200.
5. Chrzanowska-Wodnicka M, Kraus AE, Gale D, White GC 2nd, Vansluys J (2008) Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 111: 2647-2656.
6. Carmona G, Gottig S, Orlandi A, Scheele J, Bauerle T, et al. (2009) Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood 113: 488-497.
7. Chrzanowska-Wodnicka M, (2010) Regulation of angiogenesis by a small GTPase Rap1. Vascul Pharmacol 53: 1-10.
8. Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, et al. (2009) A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. Blood 114: 4592-4600.
9. Hong J, Doebele RC, Lingen MW, Quilliam LA, Tang WJ, et al. (2007) Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem 282: 19781-19787.
10. Spindler V, Schlegel N, Waschke J, (2010) Role of GTPases in control of microvascular permeability. Cardiovascular research 87: 243-253.
11. Yan J, Li F, Ingram DA, Quilliam LA, (2008) Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Molecular and cellular biology 28: 5803-5810.
12. Awasthi A, Samarakoon A, Chu H, Kamalakannan R, Quilliam LA, et al. (2010) Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes. The Journal of experimental medicine 207: 1923-1938.
13. Chu H, Awasthi A, White GC 2nd, Chrzanowska-Wodnicka M, Malarkannan S (2008) Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity. Journal of immunology 181: 3373-3383.
14. Duchniewicz M, Zemojtel T, Kolanczyk M, Grossmann S, Scheele JS, et al. (2006) Rap1A-deficient T and B cells show impaired integrin-mediated cell adhesion. Molecular and cellular biology 26: 643-653.
15. Gueders MM, Foidart JM, Noel A, Cataldo DD, (2006) Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 533: 133-144.
16. Li J, O'Connor KL, Cheng X, Mei FC, Uchida T, et al. (2007) Cyclic adenosine 5'-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways. Molecular endocrinology 21: 159-171.
17. Li Y, Yan J, De P, Chang HC, Yamauchi A, et al. (2007) Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. Journal of immunology 179: 8322-8331.
18. Zhang G, Xiang B, Ye S, Chrzanowska-Wodnicka M, Morris AJ, et al. (2011) Distinct roles for Rap1b protein in platelet secretion and integrin alphaIIbbeta3 outside-in signaling. J Biol Chem 286: 39466-39477.
19. Holz GG, Chepurny OG, Schwede F, (2008) Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal 20: 10-20.
20. Dormond O, Bezzi M, Mariotti A, Ruegg C, (2002) Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling. J Biol Chem 277: 45838-45846.
21. Dormond O, Ruegg C, (2003) Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A. Thromb Haemost. 90: 577-585.
22. Kim G, Choe Y, Park J, Cho S, Kim K, (2002) Activation of protein kinase A induces neuronal differentiation of HiB5 hippocampal progenitor cells. Brain Res Mol Brain Res 109: 134-145.
23. Kim S, Bakre M, Yin H, Varner JA, (2002) Inhibition of endothelial cell survival and angiogenesis by protein kinase A. The Journal of clinical investigation. 110: 933-941.
24. Szkudlarek M, Bosio RM, Wu Q, Chin KV, (2009) Inhibition of angiogenesis by extracellular protein kinase A. Cancer Lett. 283: 68-73.
25. Tortora G, Caputo R, Damiano V, Melisi D, Bianco R, et al. (2003) Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. Clin Cancer Res 9: 1566-1572.
26. Tortora G, Ciardiello F, (2003) Antisense targeting protein kinase A type I as a drug for integrated strategies of cancer therapy. Ann N Y Acad Sci 1002: 236-243.
27. Hashimoto A, Miyakoda G, Hirose Y, Mori T, (2006) Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189: 350-357.
28. Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, et al. (2002) Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2: 473-483.
29. Nishiyama K, Takaji K, Uchijima Y, Kurihara Y, Asano T, et al. (2007) Protein kinase A-regulated nucleocytoplasmic shuttling of Id1 during angiogenesis. J Biol Chem 282: 17200-17209.
30. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, et al. (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136: 839-851.
31. Bailey CL, Kelly P, Casey PJ, (2009) Activation of Rap1 promotes prostate cancer metastasis. Cancer research 69: 4962-4968.
32. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, et al. (2002) Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62: 1832-1837.
33. Bos JL, (1998) All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J 17: 6776-6782.
34. Bigler D, Gioeli D, Conaway MR, Weber MJ, Theodorescu D, (2007) Rap2 regulates androgen sensitivity in human prostate cancer cells. Prostate 67: 1590-1599.
35. Zwartkruis FJ, Wolthuis RM, Nabben NM, Franke B, Bos JL, (1998) Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J 17: 5905-5912.
36. Chen T, Cho RW, Stork PJ, Weber MJ, (1999) Elevation of cyclic adenosine 3′,5′-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res 59: 213-218.
37. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M, (1989) A ras-related gene with transformation suppressor activity. Cell 56: 77-84.
38. Stork PJ, (2003) Does Rap1 deserve a bad Rap? Trends Biochem Sci 28: 267-275.
39. Grandoch M, Rose A, ter Braak M, Jendrossek V, Rubben H, et al. (2009) Epac inhibits migration and proliferation of human prostate carcinoma cells. Br J Cancer 101: 2038-2042.
40. Lakshmikanthan S, Sobczak M, Chun C, Henschel A, Dargatz J, et al. (2011) Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin alphavbeta(3). Blood 118: 2015-2026.
41. Bos JL, (2005) Linking Rap to cell adhesion. Curr Opin Cell Biol 17: 123-128.
42. Kooistra MR, Dube N, Bos JL, (2007) Rap1: a key regulator in cell-cell junction formation. J Cell Sci 120: 17-22.
43. Hewer RC, Sala-Newby GB, Wu YJ, Newby AC, Bond M, (2011) PKA and Epac synergistically inhibit smooth muscle cell proliferation. J Mol Cell Cardiol 50: 87-98.